The RSV OIA rapid immunoassay is for the detection of respiratory syncytial virus (RSV), the most common cause of lower respiratory tract infections in children worldwide. In the U.S., RSV causes approximately 90,000 hospitalizations and 4,500 deaths each year in both infants and young children. RSV also causes repeated symptomatic infections throughout life.
     This company’s patented Optical ImmunoAssay technology is designed for high sensitivity and specificity, and the OIA product line includes tests for Group A Streptococcus, Influenza A and B, Chlamydia, Group B Streptococcus, and Clostridium difficile Toxin A.
Thermo BioStar
www.CLPmag.com 
Keywords: infectious disease, rapid test